Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment

H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

Wesley K. Kroeze, Sandra J. Hufeisen, Beth A Popadak et al. · Neuropsychopharmacology · 2003 · 796 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study

David C. Henderson, Enrico Cagliero, C. H. GRAY et al. · American Journal of Psychiatry · 2000 · 710 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia

Michael J. Sernyak, Douglas Leslie, Renato D. Alarcón et al. · American Journal of Psychiatry · 2002 · 624 citations

Medicine, Pharmacotherapy, Psychiatry +16

Prevalence and Correlates of Diabetes in National Schizophrenia Samples

Lisa B. Dixon, Peter J. Weiden, Janine Delahanty et al. · Schizophrenia Bulletin · 2000 · 574 citations · Full text

Medicine, Internal Medicine, Psychiatry +17

Novel antipsychotics: comparison of weight gain liabilities.

Donna A. Wirshing, W C Wirshing, Lisa Kysar et al. · PubMed · 1999 · 527 citations

Pharmacy, Pharmacotherapy, Psychiatry +15